Stay updated on Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial
Sign up to get notified when there's something new on the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page.

Latest updates to the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page
- Check5 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0, indicating a new build or documentation update reflected on the page.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, signaling a minor update to the page's metadata.SummaryDifference0.1%

- Check26 days agoChange Detected- A new funding attribution line '2018 ( U.S. NIH Grant/Contract )' was added to the study identifiers section. This indicates NIH support for the trial.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page now shows revision v3.6.5, replacing the previous v3.6.4. This reflects a deployment update and does not alter the study information presented.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page's revision label changed from v3.6.3 to v3.6.4, representing a small, non-substantive update to the page version.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision label updated from Revision: v3.6.0 to Revision: v3.6.3, indicating a backend or UI update rather than a change to the study details.SummaryDifference0.1%

Stay in the know with updates to Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page.